ABL Bio

298380.KQ

167.49 USD

32.43

+24.01%

Overview

Last close

167.49 usd

Market cap

9.23B usd

52 week high

167.49 usd

52 week low

18.25 usd

Target price

86.53 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

147.7293

Price/Book Value

59.8833

Enterprise Value

7.53B usd

EV/Revenue

122.4726

EV/EBITDA

-32.1061

Key financials

Revenue TTM

61.46M usd

Gross Profit TTM

61.42M usd

EBITDA TTM

-18.59M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

167.77M usd

Net debt

N/A usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.